Warning letter
Medical Positioning Inc. [ARCHIVED]: warning letter of Apr 18, 2011
FDA warning letter 162812 · Kansas City District Office
Key facts
| Reference number | 162812 |
|---|---|
| Company | Medical Positioning Inc. [ARCHIVED] |
| Subject | CGMP/QSR/Adulterated/Misbranded |
| Issue date | Apr 18, 2011 |
| Posted date | Apr 18, 2011 |
| Issuing office | Kansas City District Office |
| Product type | Devices |
| CFR sections cited | 820, 820.40, 803, 806, 806.10(c)(11), 806.20(b)(4) |
| Inspection city | Lenexa |
| Inspection ZIP | 66215 |
| Inspection start date | Dec 20, 2010 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: